Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Last Updated: April 2, 2026, 4:40 am
Author: Getaka|Social: XLinkedIn
Stock Ticker - BSE: 531592 | NSE: GENPHARMA

Genpharmasec Ltd: Intrinsic Value & Share Price Analysis

Fair Value

₹0.28Overvalued by 69.89%vs CMP ₹0.93

P/E (15.0) × ROE (1.9%) × BV (₹1.19) × DY (2.00%)

Defaults: P/E=15

₹0.43Overvalued by 53.76%vs CMP ₹0.93
MoS: -116.3% (Negative)Confidence: 50/100 (Moderate)Models: 1 Under, 1 Fair, 5 Over
ModelCategoryValueWeightSignal
PE-ROEEarnings₹0.2725%Over (-71%)
Graham NumberEarnings₹0.7319%Over (-21.5%)
DCFCash Flow₹0.0419%Over (-95.7%)
Net Asset ValueAssets₹1.1910%Under (+28%)
Earnings YieldEarnings₹0.2010%Over (-78.5%)
ROCE CapitalReturns₹0.1110%Over (-88.2%)
Revenue MultipleRevenue₹0.918%Fair (-2.2%)
Consensus (7 models)₹0.43100%Overvalued
Key Drivers: ROE 1.9% is below cost of equity. | Wide model spread (₹0–₹1) — high uncertainty.

PE-ROE · Graham · EPV · DCF · NAV · EV/EBITDA · DDM · Earnings Yield · ROCE Capital · Revenue Multiple | CoE: 12% · Terminal: 4% · EPS CAGR: -0.7% · Defaults: P/E=15

*Investments are subject to market risks

Investment Snapshot

41
Genpharmasec Ltd scores 41/100 (Weak)
Based on 5 dimensions: health, institutional flow, earnings quality, momentum, and peer comparison
Stock Health38/100 · Weak
ROCE 3.4% WeakROE 1.9% WeakD/E 0.04 Low debtInterest Coverage 0.0x RiskyProfitable 2/5 years Inconsistent
Smart Money50/100 · Moderate
Promoter holding at 30.0% Stable
Earnings Quality40/100 · Moderate
OPM stable around 0% SteadyWorking capital: 141 days Capital intensive
Quarterly Momentum50/100 · Moderate
Revenue (4Q): +229% YoY AcceleratingProfit (4Q): -170% YoY DecliningOPM: -3.1% (down 11.6% YoY) Margin pressure
Industry Rank30/100 · Weak
ROCE 3.4% vs industry 15.2% Below peersROE 1.9% vs industry 8.8% Below peers

Weights: Health 30% · Earnings Quality 25% · Momentum 20% · Industry Rank 15% · Smart Money 10%. Scores are computed from reported financials and recalculated daily. Not investment advice.

Genpharmasec Ltd Investor Signals

Computed from valuation, cash flow, balance sheet, ownership and quarterly trend data already available in this stock page.

Value Trap Score
60/100
Moderate
Derived from: Cheapness + weak quality + weak cash support
Current data: P/E 0.0 vs Ind 102.1 | ROCE 3.4% | ROE 1.9% | CFO/NP N/A
Balance Sheet Stress
40/100
Manageable
Derived from: Leverage + debt servicing + liquidity + debt trend
Current data: D/E 0.04x | IntCov 0.0x | Current 15.16x | Borrow/Reserve 1.07x
Cash Flow Reliability
43/100
Mixed
Derived from: Cash backing of earnings + working capital pressure
Current data: CFO ₹0 Cr | NP ₹1 Cr | CFO/NP N/A
Ownership Accumulation
0
Neutral
Derived from: FII + DII + promoter direction, adjusted by crowding
Current data: FII N/A | DII N/A | Prom 0.00 pp
Business Momentum
+15
Watch closely
Derived from: Latest quarter sales + profit + OPM change
Current data: Q Sales +22.0% | Q NP +29.7% | Q OPM -1.7 pp
Derived FieldValueHow it is derived
Valuation Gap %-53.8%((Fair Value - CMP) / CMP) × 100
Borrowings / Reserves1.07xLatest borrowings divided by latest reserves
CFO / Net ProfitN/ALatest operating cash flow divided by latest net profit
FII ChangeN/ALatest FII% minus previous FII%
DII ChangeN/ALatest DII% minus previous DII%
Promoter Change0.00 ppLatest promoter% minus previous promoter%
Shareholder Count Change-1,783Latest shareholder count minus previous count
Quarterly Sales Change+22.0%Latest quarter sales vs previous quarter sales
Quarterly Profit Change+29.7%Latest quarter net profit vs previous quarter net profit
Quarterly OPM Change-1.7 ppLatest quarter OPM minus previous quarter OPM

Share Price and Basic Stock Data

Last Updated: April 2, 2026, 4:40 am

Market Cap 51.5 Cr.
Current Price 0.93
Intrinsic Value₹0.43
High / Low 2.38/0.75
Stock P/E
Book Value 1.19
Dividend Yield0.00 %
ROCE3.35 %
ROE1.90 %
Face Value 1.00
PEG Ratio0.00

Stock P/E, Current Price, and Intrinsic Value Over Time

View Share Price Target for Genpharmasec Ltd

Competitors

Stock Name ⇩Market Cap ⇩Current Price ⇩High / Low ⇩Stock P/E ⇩Book Value ⇩Dividend Yield ⇩ROCE ⇩ROE ⇩Face Value ⇩
Millennium Online Solutions (India) Ltd 7.00 Cr. 1.40 2.88/1.29 0.810.00 %4.61 %5.54 % 1.00
Minal Industries Ltd 41.6 Cr. 2.17 5.59/1.78102 2.780.00 %5.97 %2.83 % 2.00
Mitshi India Ltd 12.5 Cr. 14.2 17.5/11.5 3.090.00 %0.36 %0.37 % 10.0
Modella Woollens Ltd 5.42 Cr. 59.6 74.8/52.5 4.950.00 %%% 10.0
MRC Agrotech Ltd 98.2 Cr. 31.3 54.5/10.5109 15.10.00 %5.89 %4.46 % 10.0
Industry Average10,858.54 Cr140.30102.09119.050.48%15.22%8.81%7.62

All Competitor Stocks of Genpharmasec Ltd

Quarterly Result

MetricMar 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Sales 6.227.866.3810.205.206.038.4814.0112.0432.6439.83
Expenses 6.017.896.3710.215.005.907.7615.0111.1033.1041.07
Operating Profit 0.21-0.030.01-0.010.200.130.72-1.000.94-0.46-1.24
OPM % 3.38%-0.38%0.16%-0.10%3.85%2.16%8.49%-7.14%7.81%-1.41%-3.11%
Other Income 0.060.150.140.310.570.750.810.940.690.460.98
Interest 0.060.070.000.160.100.070.160.110.120.230.41
Depreciation 0.010.000.120.030.160.300.100.260.270.560.67
Profit before tax 0.200.050.030.110.510.511.27-0.431.24-0.79-1.34
Tax % -420.00%80.00%-100.00%345.45%35.29%-39.22%40.16%-37.21%2.42%48.10%-37.31%
Net Profit 1.050.010.06-0.270.330.700.76-0.271.22-1.18-0.83
EPS in Rs 0.020.000.00-0.000.010.010.01-0.000.02-0.02-0.01

Last Updated: March 3, 2026, 9:36 am

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: February 27, 2026, 5:46 am

MetricMar 2023Mar 2024Mar 2025TTM
Sales 25.5230.4133.5798.52
Expenses 25.2630.3733.49100.28
Operating Profit 0.260.040.08-1.76
OPM % 1.02%0.13%0.24%-1.79%
Other Income 0.100.663.063.07
Interest 0.060.410.450.87
Depreciation 0.020.040.811.76
Profit before tax 0.280.251.88-1.32
Tax % -300.00%168.00%34.57%
Net Profit 1.12-0.171.23-1.06
EPS in Rs 0.02-0.000.02-0.01
Dividend Payout % 0.00%0.00%0.00%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year2023-20242024-2025
YoY Net Profit Growth (%)-115.18%823.53%
Change in YoY Net Profit Growth (%)0.00%938.71%

Genpharmasec Ltd has shown a consistent positive trend in YoY Net Profit Growth (%) in the last 2 years from 2023-2024 to 2024-2025.

Growth

Compounded Sales Growth
10 Years:%
5 Years:%
3 Years:%
TTM:37%
Compounded Profit Growth
10 Years:%
5 Years:%
3 Years:%
TTM:1769%
Stock Price CAGR
10 Years:22%
5 Years:-22%
3 Years:-9%
1 Year:-44%
Return on Equity
10 Years:%
5 Years:%
3 Years:%
Last Year:2%

Last Updated: September 5, 2025, 3:36 pm

Balance Sheet

Last Updated: December 4, 2025, 2:57 am

MonthMar 2023Mar 2024Mar 2025Sep 2025
Equity Capital 27.6955.3755.3755.37
Reserves -12.369.029.7910.31
Borrowings 3.083.895.2811.01
Other Liabilities 1.462.849.4547.31
Total Liabilities 19.8771.1279.89124.00
Fixed Assets 0.100.847.5842.20
CWIP 0.000.000.000.00
Investments 0.9519.3218.842.05
Other Assets 18.8250.9653.4779.75
Total Assets 19.8771.1279.89124.00

Reserves and Borrowings Chart

Cash Flow

MonthMar 2023Mar 2024Mar 2025
Cash from Operating Activity + -3.06-2.952.99
Cash from Investing Activity + 0.36-28.06-15.30
Cash from Financing Activity + 3.0847.85-1.25
Net Cash Flow 0.3916.84-13.56
Free Cash Flow -3.08-2.97-2.72
CFO/OP -1,277%-7,275%3,825%

Free Cash Flow

MonthMar 2023Mar 2024Mar 2025
Free Cash Flow-2.82-3.85-5.20

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

MonthMar 2023Mar 2024Mar 2025
Debtor Days 81.67109.22147.21
Inventory Days 151.06133.17101.29
Days Payable 21.3835.85102.03
Cash Conversion Cycle 211.34206.54146.47
Working Capital Days 199.09213.17141.26
ROCE %1.52%3.32%

Financial Efficiency Indicators Chart

Share Holding Pattern

MonthMar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Promoters 59.96%59.96%59.96%59.96%29.98%29.98%29.98%29.98%29.98%29.98%29.98%29.98%
Public 40.03%40.03%40.04%40.04%70.02%70.02%70.02%70.02%70.02%70.02%70.03%70.01%
No. of Shareholders 49,76048,86854,45889,4381,08,1371,08,2201,05,8381,09,2061,09,0801,07,6021,05,8041,04,021

Shareholding Pattern Chart

No. of Shareholders

Genpharmasec Ltd: Intrinsic Value & Share Price Analysis - Shareholder trend analysis

This stock is not held by any mutual fund.

ROCE Trend

EPS Trend

Key Financial Ratios

MonthMar 25Mar 24
FaceValue 1.001.00
Basic EPS (Rs.) 0.02-0.01
Diluted EPS (Rs.) 0.02-0.01
Cash EPS (Rs.) 0.030.00
Book Value[Excl.RevalReserv]/Share (Rs.) 1.181.17
Book Value[Incl.RevalReserv]/Share (Rs.) 1.181.17
Revenue From Operations / Share (Rs.) 0.600.54
PBDIT / Share (Rs.) 0.050.01
PBIT / Share (Rs.) 0.040.01
PBT / Share (Rs.) 0.030.00
Net Profit / Share (Rs.) 0.020.00
NP After MI And SOA / Share (Rs.) 0.020.00
PBDIT Margin (%) 9.272.30
PBIT Margin (%) 6.862.16
PBT Margin (%) 5.570.82
Net Profit Margin (%) 3.65-0.55
NP After MI And SOA Margin (%) 3.58-0.41
Return on Networth / Equity (%) 1.85-0.19
Return on Capital Employeed (%) 3.300.96
Return On Assets (%) 1.51-0.17
Long Term Debt / Equity (X) 0.040.04
Total Debt / Equity (X) 0.040.04
Asset Turnover Ratio (%) 0.440.00
Current Ratio (X) 2.7815.16
Quick Ratio (X) 1.9411.89
Inventory Turnover Ratio (X) 3.960.00
Interest Coverage Ratio (X) 7.191.72
Interest Coverage Ratio (Post Tax) (X) 3.830.58
Enterprise Value (Cr.) 102.64108.00
EV / Net Operating Revenue (X) 3.043.55
EV / EBITDA (X) 32.83153.89
MarketCap / Net Operating Revenue (X) 3.104.06
Price / BV (X) 1.611.92
Price / Net Operating Revenue (X) 3.104.06
EarningsYield 0.010.00

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

About the Company - Qualitative Analysis

Genpharmasec Ltd. is a Public Limited Listed company incorporated on 16/11/1992 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L24231MH1992PLC323914 and registration number is 018572. Currently company belongs to the Industry of Trading & Distributors. Company's Total Operating Revenue is Rs. 32.96 Cr. and Equity Capital is Rs. 55.37 Cr. for the Year ended 31/03/2025.
INDUSTRYADDRESSCONTACT
Trading & DistributorsOffice No. 104 & 105 (1st Floor), Gundecha Industrial Premises Co-Operative Society Ltd., Mumbai Maharashtra 400101Contact not found
Management
NamePosition Held
Mr. Sohan ChaturvediWholeTime Director & CFO
Mrs. Sneha SadhwaniNon Exe.Non Ind.Director
Mr. Rajesh SadhwaniNon Exe.Non Ind.Director
Mr. Siddhesh ShendeIndependent Director
Mr. Mayur BhattIndependent Director
Mr. Sachin AphandkarIndependent Director

FAQ

What is the intrinsic value of Genpharmasec Ltd and is it undervalued?

As of 05 April 2026, Genpharmasec Ltd's intrinsic value is ₹0.43, which is 53.76% lower than the current market price of ₹0.93, suggesting the stock is overvalued. This is calculated using the PE ratio method factoring in ROE (1.90 %), book value (₹1.19), dividend yield (0.00 %), and 5-year EPS CAGR.

What is the current share price and 52-week range of Genpharmasec Ltd?

Genpharmasec Ltd is trading at ₹0.93 as of 05 April 2026, with a FY2026-2027 high of ₹2.38 and low of ₹0.75. The stock is currently near its 52-week low. Market cap stands at ₹51.5 Cr..

How does Genpharmasec Ltd's P/E ratio compare to its industry?

Genpharmasec Ltd has a P/E ratio of , which is below the industry average of 102.09. This is broadly in line with or below the industry average.

Is Genpharmasec Ltd financially healthy?

Key indicators for Genpharmasec Ltd: ROCE of 3.35 % is on the lower side compared to the industry average of 15.22%; ROE of 1.90 % is below ideal levels (industry average: 8.81%). Dividend yield is 0.00 %.

Is Genpharmasec Ltd profitable and how is the profit trend?

Genpharmasec Ltd reported a net profit of ₹1 Cr in Mar 2025 on revenue of ₹34 Cr. Compared to ₹1 Cr in Mar 2023, the net profit shows an improving trend.

Does Genpharmasec Ltd pay dividends?

Genpharmasec Ltd has a dividend yield of 0.00 % at the current price of ₹0.93. The company is currently not paying meaningful dividends.

Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Genpharmasec Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE
Explore Industry-wise Stock Analysis Reports